Shashank R. Joshi

Shashank R. Joshi is an Indian endocrinologist, diabetologist and medical researcher, considered by many as one of the prominent practitioners of the trade in India. He was honoured by the Government of India, in 2014, by bestowing on him the Padma Shri, the fourth highest civilian award, for his services to the field of medicine. He is a part of the COVID-19 Task Force for the state of Maharashtra, India. Provided by Wikipedia
Showing 1 - 17 results of 17 for search 'Shashank Joshi', query time: 0.05s Refine Results
  1. 1
    Angiotensin converting enzyme (ACE)-2: Beyond just the entry point for the SARS-CoV-2: A commentary

    Angiotensin converting enzyme (ACE)-2: Beyond just the entry point for the SARS-CoV-2: A commentary by Viraj Suvarna, Shashank Joshi

    Published 2021-01-01
    Get full text
    Article
  2. 2
    Academic endocrinology in India: Forty, fifteen or both?

    Academic endocrinology in India: Forty, fifteen or both? by Sanjay Kalra, Ambika Gopalakrishnan Unnikrishnan, Shashank Joshi

    Published 2011-01-01
    Get full text
    Article
  3. 3
    A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy.

    A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy. by Alka Deshpande, Harsh Toshniwal, Shashank Joshi, Rajendrakumar H Jani

    Published 2016-01-01
    Get full text
    Article
  4. 4
    Cardiovascular safety of hydroxychloroquine: Brief appraisal of data

    Cardiovascular safety of hydroxychloroquine: Brief appraisal of data by Anil Pareek, Shashank Joshi, Ashok K Das, Ravi Tejraj Mehta

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Effectiveness and Safety of Fixed-dose Combination of Perindopril/Amlodipine/Indapamide, and Telmisartan/Amlodipine/Chlorthalidone in Grade 2 Hypertensive Patients at High Cardiovascular Risk: A Real-world Observational Study

    Effectiveness and Safety of Fixed-dose Combination of Perindopril/Amlodipine/Indapamide, and Telmisartan/Amlodipine/Chlorthalidone in Grade 2 Hypertensive Patients at High Cardiova... by Shambo Samrat Samajdar, Shatavisa Mukherjee, Santanu Kumar Tripathi, Jyotirmoy Pal, Shashank Joshi

    Published 2023-01-01
    Get full text
    Article
  6. 6
    Effectiveness of budesonide formoterol fixed-dose combination MDI in reducing cough symptoms in COVID-19 patients: A real-world evidence study

    Effectiveness of budesonide formoterol fixed-dose combination MDI in reducing cough symptoms in COVID-19 patients: A real-world evidence study by Shambo Samrat Samajdar, Shatavisa Mukherjee, Saibal Moitra, Jyotirmoy Pal, Shashank Joshi, Santanu Kumar Tripathi

    Published 2023-01-01
    Get full text
    Article
  7. 7
    Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study

    Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study by Sunil Gupta, Kavita Gupta, R Ravi, Vinita Mehta, Samar Banerjee, Shashank Joshi, Banshi Saboo

    Published 2015-01-01
    Get full text
    Article
  8. 8
    Author's response

    Author's response by Shambo Samrat Samajdar, Shatavisa Mukherjee, Saibal Moitra, Jyotirmoy Pal, Shashank Joshi, Santanu Kumar Tripathi

    Published 2023-01-01
    Get full text
    Article
  9. 9
    Diabetes and coronavirus disease-2019 (COVID-19)

    Diabetes and coronavirus disease-2019 (COVID-19) by Ranjit Unnikrishnan, Banshi Saboo, Jothydev Kesavadev, Neeta Deshpande, Sosale Ramachandra Aravind, Shashank Joshi, Ranjit Mohan Anjana, Akhtar Hussain, Viswanathan Mohan

    Published 2020-01-01
    Get full text
    Article
  10. 10
    Credibility Analysis of User-Designed Content Using Machine Learning Techniques

    Credibility Analysis of User-Designed Content Using Machine Learning Techniques by Milind Gayakwad, Suhas Patil, Amol Kadam, Shashank Joshi, Ketan Kotecha, Rahul Joshi, Sharnil Pandya, Sudhanshu Gonge, Suresh Rathod, Kalyani Kadam, Maya Shelke

    Published 2022-04-01
    Get full text
    Article
  11. 11
    Type 2 diabetes reversal with digital twin technology-enabled precision nutrition and staging of reversal: a retrospective cohort study

    Type 2 diabetes reversal with digital twin technology-enabled precision nutrition and staging of reversal: a retrospective cohort study by Paramesh Shamanna, Shashank Joshi, Lisa Shah, Mala Dharmalingam, Banshi Saboo, Jahangir Mohammed, Maluk Mohamed, Terrence Poon, Nathan Kleinman, Mohamed Thajudeen, Ashok Keshavamurthy

    Published 2021-11-01
    Get full text
    Article
  12. 12
    IMPACT India: A novel approach for optimum diabetes care

    IMPACT India: A novel approach for optimum diabetes care by Ashok K Das, Viswanathan Mohan, Shashank Joshi, Siddharth Shah, Abdul Hamid Zargar, Sanjay Kalra, Ambika Gopalakrishnan Unnikrishnan, Ajay Kumar, Ambrish Mithal, Nikhil Tandon

    Published 2021-01-01
    Get full text
    Article
  13. 13
    Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study

    Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study by Shashi Bhushan B L, Sunil Wanve, Parshottam Koradia, Vinay Bhomia, Pravin Soni, Sisir Chakraborty, Akash Khobragade, Shashank Joshi, Sanjeev Kumar Mendiratta, Kevin Kumar Kansagra, Anurag Parihar, Sunil Sharma, Jatin Patel

    Published 2021-10-01
    Get full text
    Article
  14. 14
    Role of diabetes technology for diabetes prevention and improving public health outcomes: A position statement by Diabetes Technology Trust of India

    Role of diabetes technology for diabetes prevention and improving public health outcomes: A position statement by Diabetes Technology Trust of India by Amit Gupta, Banshi Saboo, Jothydev Kesavadev, Manoj Chawla, Rakesh Parikh, Mithun Bhartia, Shashank Joshi, Sanjay Kalra, A G Unnikrishnan, Anuj Maheshwari, Sanjay Agarwal, Brij Makkar, Purvi Chawla, Jayant Panda, Tanvir Kaur, Ashok Kumar Das, Viswanthan Mohan

    Published 2023-01-01
    Get full text
    Article
  15. 15
    Two‐year trends from the LANDMARC study: A 3‐year, pan‐India, prospective, longitudinal study on the management and real‐world outcome in patients with type 2 diabetes mellitus

    Two‐year trends from the LANDMARC study: A 3‐year, pan‐India, prospective, longitudinal study on the management and real‐world outcome in patients with type 2 diabetes mellitus... by Ashok K. Das, Sanjay Kalra, Shashank Joshi, Ambrish Mithal, Prasanna Kumar K. M., Ambika G. Unnikrishnan, Hemant Thacker, Bipin Sethi, Subhankar Chowdhury, Amarnath Sugumaran, Senthilnathan Mohanasundaram, Shalini K. Menon, Vaibhav Salvi, Deepa Chodankar, Saket Thaker, Chirag Trivedi, Subhash K. Wangnoo, Abdul H. Zargar, Nadeem Rais

    Published 2023-03-01
    Get full text
    Article
  16. 16
    The LongitudinAl Nationwide stuDy on Management And Real‐world outComes of diabetes in India over 3 years (LANDMARC trial)

    The LongitudinAl Nationwide stuDy on Management And Real‐world outComes of diabetes in India over 3 years (LANDMARC trial) by Ashok K. Das, Sanjay Kalra, Shashank Joshi, Ambrish Mithal, K. M. Prasanna Kumar, A. G. Unnikrishnan, Hemant Thacker, Bipin Sethi, Subhankar Chowdhury, Amarnath Sugumaran, Ashwini Satpathy, Arvind Gadekar, Shalini K. Menon, Renuka Neogi, Deepa Chodankar, Chirag Trivedi, S. K. Wangnoo, A. H. Zargar, Nadeem Rais, LANDMARC study group

    Published 2023-09-01
    Get full text
    Article
  17. 17
    One‐year trends from the LANDMARC trial: A 3‐year, pan‐India, prospective, longitudinal study on the management and real‐world outcomes of type 2 diabetes mellitus

    One‐year trends from the LANDMARC trial: A 3‐year, pan‐India, prospective, longitudinal study on the management and real‐world outcomes of type 2 diabetes mellitus by Ashok K. Das, Sanjay Kalra, Shashank Joshi, Ambrish Mithal, Prasanna Kumar K. M., Ambika G. Unnikrishnan, Hemant Thacker, Bipin Sethi, Subhankar Chowdhury, Romik Ghosh, Sukanya Krishnan, Arjun Nair, Senthilnathan Mohanasundaram, Shalini K. Menon, Vaibhav Salvi, Deepa Chodankar, Saket Thaker, Chirag Trivedi, Subhash K. Wangnoo, Abdul H. Zargar, Nadeem Rais

    Published 2022-01-01
    Get full text
    Article

Search Tools: